Danielle

Quick links to important sections

Danielle

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Danielle

Overview of Danielle

Danielle is a combined oral contraceptive pill used primarily for the prevention of pregnancy. It contains two types of female hormones: an estrogen and a progestogen. Because it contains two different hormones, it is classified as a combined pill.

Composition and Mechanism

The active components in Danielle work together to prevent conception through several biological pathways:

  • Inhibition of Ovulation: The primary action is the suppression of the release of an egg from the ovaries each month.
  • Cervical Mucus Alteration: The hormones increase the thickness of the mucus at the neck of the womb, making it more difficult for sperm to enter the uterus.
  • Endometrial Modification: The treatment alters the lining of the womb to make it less receptive to the implantation of a fertilized egg.

Additional Applications

Beyond its primary use as a contraceptive, Danielle is sometimes utilized for the management of specific hormonal conditions in women. These may include:

  • Menstrual Cycle Regulation: It can help establish more regular and predictable menstrual patterns.
  • Reduction of Menstrual Symptoms: The treatment is often used to decrease the intensity of menstrual cramps and reduce the volume of heavy menstrual bleeding.
  • Management of Acne: In some instances, the hormonal balance provided by the pill can assist in the treatment of moderate acne in women who also require contraception.

Understanding Hormone Therapy

As a hormonal medication, Danielle interacts with the body's natural endocrine system. It is designed to maintain steady hormone levels throughout the cycle to ensure its effectiveness. The use of this medication is typically a long-term approach to reproductive health and hormonal management.

Regulatory References

  1. Contraception - World Health Organization (WHO)

What side effects are possible with Danielle?

Possible side effects and safety information for Danielle

The safety profile of [Danielle] is documented through its official regulatory labeling, which categorizes potential adverse reactions by system-organ class and frequency.

Adverse Reaction Categories

Adverse reactions are classified using standard frequency definitions (e.g., Very Common ge 1/10, Common ge 1/100 to < 1/10). The key System-Organ Classes involved typically include Gastrointestinal Disorders, Nervous System Disorders, Immune System Disorders, and Blood and Lymphatic System Disorders.

Frequency Examples of Documented Reactions
Very Common Fatigue, headache, nausea, or diarrhea.
Common Insomnia, rash, or injection site reactions.

Serious and Clinically Significant Adverse Reactions

The regulatory labeling identifies specific serious adverse reactions that require heightened awareness. These typically include events such as Severe Hypersensitivity Reactions (including anaphylaxis), Hepatotoxicity (clinically significant elevation of liver enzymes or acute liver failure), and Hematological Abnormalities (severe or persistent cytopenias). A formal Boxed Warning or comparable governmental caution may be present to highlight the risk of these serious outcomes.

Safety-Related Restrictions and Considerations

The use of [Danielle] is subject to certain population-specific safety considerations. For example, use in women of childbearing potential may require mandatory contraception due to documented risks of embryofetal toxicity. Furthermore, the product is contraindicated in patients with a history of severe allergic reaction to the active substance or in combination with specific strong drug interactions. The labeling requires pre-treatment screening and periodic monitoring of specific laboratory parameters (e.g., liver function tests, complete blood counts) throughout the treatment course to detect potential adverse reactions early.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information indicates that an acute overdose of Danielle (Dienogest/Ethinyl Estradiol) is generally classified as not life-threatening. However, immediate medical attention is required in the event of any suspected overdose or accidental ingestion, regardless of the initial symptoms.


Documented Overdose Signs and Required Actions

Classification Official Regulatory Statement
Documented Presentations Nausea, Vomiting, and Vaginal Bleeding (withdrawal bleeding).
Emergency Protocol Seek emergency medical attention immediately. Call the Poison Help line or your regional Poison Control center.
Severity Acute overdose is generally not associated with serious long-term sequelae.
Special Consideration Overdose symptoms may occur following accidental ingestion by children.

Management Classification

Treatment for this type of overdose is symptomatic and supportive. No specific antidote is known or documented in the official prescribing information. Medical assessment and supportive care are necessary to manage any symptoms that may arise.

Therapeutic Uses of Danielle

What Danielle Treats: Main Uses and Benefits

The combination of Dienogest and Ethinyl Estradiol is commonly used to help with symptoms related to systemic imbalance and the management of certain symptomatic conditions. Its primary use is to support the prevention of pregnancy. Medicines containing this combination are also relevant for both contraception and the symptomatic management of mild to moderate acne vulgaris.


Therapeutic Scope and Symptom Relief

This contraceptive is commonly used to help with symptom clusters that may become intense or disruptive, including severe menstrual pain (dysmenorrhea) and abnormally heavy or prolonged bleeding (menorrhagia). The medication may be part of symptomatic management in clinical scenarios where the patient requires assistance with fertility control alongside supportive relief for menstrual discomfort or androgen-related skin issues. The primary benefit provides support that helps ease the overall symptom burden and supports the patient during difficult episodes by easing distress.


Quick Fact: Relief for Androgen-Related Symptoms
Symptoms related to physical discomfort may be part of symptomatic management due to the specific composition, contributing to improved comfort during symptomatic periods.

Regulatory References

  1. European Medicines Agency

Eligibility and Restrictions for Use

Eligibility Scope

Danielle is officially indicated for use by women of reproductive age who require contraception. Its use for managing acne symptoms is only permitted when the patient also elects to use an oral contraceptive.


Contraindicated Populations (Absolute Ban)

Official regulatory documents define numerous populations who must not use this medicine. These exclusions are primarily due to the increased risk of severe vascular events and hormonal sensitivity:

  • Vascular/Thrombotic Risk: History of blood clots (VTE/ATE), known hypercoagulopathies, or migraine with focal neurological symptoms.
  • Cardiovascular Conditions: Females over age 35 who smoke, or those with uncontrolled hypertension or diabetes with vascular involvement.
  • Hormone-Sensitive Disease: History of breast cancer or any other estrogen-sensitive cancer, and liver tumors or severe hepatic disease.

Age and Physiological Restrictions

  • Age: The pill is not indicated for use prior to menarche or in postmenopausal women.
  • Pregnancy/Lactation: Use is contraindicated during pregnancy and not recommended while breastfeeding due to potential milk production effects.
  • Surgery: Use must be discontinued four weeks before and two weeks after major surgery involving prolonged immobilization.

This structure reflects the mandated eligibility criteria that define who may safely be prescribed this combined hormonal contraceptive, as established by global regulatory authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify interactions with this medicine based on their potential to alter the drug's concentration in the body, primarily through effects on drug-metabolizing enzymes and transport proteins. Certain combinations are explicitly restricted or require procedural changes to maintain effectiveness.

Interacting Medicine Class Official Regulatory Constraint
Strong CYP3A4 Inducers Co-administration is generally not recommended due to the risk of significantly decreased plasma levels of [Danielle], which may result in loss of therapeutic effect. Examples include rifampin and some anticonvulsants.
Strong/Moderate CYP3A4 Inhibitors These medicines may significantly increase the plasma concentration of [Danielle]. Co-administration may require an explicitly stated dose reduction for [Danielle] to limit the risk of increased exposure.
Products Containing Polyvalent Cations Medicines or supplements containing iron, calcium, or aluminum may reduce absorption. Co-administration requires a defined time-spacing rule, such as administration 2 hours before or 6 hours after the cation-containing product.
Hepatitis C combination therapies Specific combinations of medications for Hepatitis C, such as those containing ombitasvir/paritaprevir/ritonavir and dasabuvir, or glecaprevir/pibrentasvir, are listed in official labeling and should not be co-administered with [Danielle].

These mandated constraints, including time separation and dose reduction requirements, are documented to manage the risk of altered exposure and maintain the expected pharmacological profile. The official interaction profile dictates which combinations must be avoided outright and which require specific, regulated modifications to the treatment plan.

Mechanism of Action

How Danielle Works: Mechanism of Action

The pharmacological effect of Danielle is achieved by the coordinated, multi-layered mechanistic actions of its two components, Dienogest and Ethinyl Estradiol, focused on modulating reproductive endocrine and peripheral systems.

Central Suppression of the HPO Axis and Ovulation Inhibition

The primary mechanism involves the synthetic hormones acting as agonists at Estrogen and Progesterone Receptors in the hypothalamus and pituitary gland, establishing a robust negative feedback signal. This central action functionally inhibits the release of FSH (preventing follicle maturation) and blocks the necessary LH surge, which together result in anovulation (the cessation of egg release).

Dual-Layered Antiandrogenic Modulation

This component acts via a synergistic mechanism to alter the activity of male hormones in the body. Dienogest provides direct antagonism at the Androgen Receptor, blocking hormonal binding at the tissue level. Simultaneously, Ethinyl Estradiol modulates hepatic synthesis to significantly increase SHBG, which binds and inactivates circulating free androgens, leading to a substantial reduction in active androgen levels.

Peripheral Barrier Creation and Tissue Effects

Acting at the periphery, primarily due to the progestogenic component, the drug modulates tissue characteristics in the lower reproductive tract. This includes inducing the cervical glands to secrete a thick, viscous mucus that creates a physical barrier to sperm passage, and causing endometrial thinning, which alters the uterine lining's receptivity.

Dosage and Administration Information

Official Administration Guidelines

Danielle, containing dienogest and ethinyl estradiol, is administered exclusively by the oral route as a film-coated tablet. Its use is defined by a rigorous 28-day cyclic dosing schedule, which is the fundamental pattern for this treatment.

Dosing and Frequency

The standard regimen for adults and postpubertal adolescents is one tablet taken daily at approximately the same time each day. A common schedule involves taking 21 consecutive days of active, hormone-containing tablets, followed by a 7-day hormone-free interval (placebo or no tablets).

The tablets must be taken in the precise order directed on the blister pack to ensure the correct hormonal sequence. Intake consistency is critical; tablets should not be skipped or intake delayed by more than 12 hours. If severe vomiting or diarrhea occurs within 3 to 4 hours of taking an active tablet, it must be treated as a missed dose. The tablet may be taken with or without food.

Course Continuation

Treatment is intended for the desired duration of contraception. To maintain the cycle, the next blister pack must be initiated immediately after the 7-day tablet-free interval is complete, irrespective of the presence or absence of a withdrawal bleed. Starting on a day other than Day 1 of the menstrual cycle usually necessitates the temporary use of a non-hormonal barrier method for the initial active tablet period.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Danielle (Dienogest/Ethinyl Estradiol)

Evidence for Use in Pregnancy Prevention (Contraception)

Research has explored the use of this combination primarily in Adult Women of Reproductive Age through several kinds of studies, including large-scale observational studies and controlled Phase III Clinical Trials. Researchers monitored key outcome measures, such as the Pearl Index, which measures the rate of unplanned pregnancies, and the frequency of Ovulation Inhibition, which is a measured endpoint in the studies. Findings documented differences in the rate of unplanned pregnancies reported under conditions of perfect use versus typical use, reflecting the challenge of real-world consistency.

Evidence for Managing Mild to Moderate Acne Vulgaris

Research examined the use of this pill for mild to moderate acne vulgaris in Adult Women of Reproductive Age who also sought oral contraception. The research foundation includes Randomized Controlled Trials (RCTs). Researchers monitored measurable outcomes, including the count of Total Acne Lesions and physician-reported scores like the Investigator Global Assessment (IGA). Research describes that the results apply only to the populations studied, as the research largely excluded individuals with severe acne or those already taking certain systemic acne medications.

Evidence for Managing Severe Menstrual Pain (Dysmenorrhea) and Heavy Bleeding

This combination was studied for both severe menstrual pain (dysmenorrhea) and heavy or prolonged bleeding (menorrhagia) using RCTs and other controlled clinical trials. For pain, research examined patient-reported outcomes describing perceived discomfort. For heavy bleeding, studies monitored the measured Menstrual Blood Loss (MBL) Volume and related hematologic indicators. Data for pain relief relies heavily on patient self-assessment, which is a factor documented in the study limitations.

What Is Still Uncertain About Danielle (Evidence Gaps)

The current evidence landscape highlights areas where knowledge is still developing. Sample sizes were modest or follow-up durations were limited in some trials, meaning certainty remains low regarding outcomes after many years of use. Comparative evidence remains limited for a definitive comparison of this combination against every other available oral contraceptive for non-contraceptive benefits like acne relief. Data for certain groups remain insufficient, particularly for patients with severe symptoms or those with complex existing medical conditions.

Frequently Asked Questions (FAQ)

Common questions about Danielle (FAQ)


Q: How quickly should I expect Danielle to start working?

If administration begins outside of the first day of the menstrual cycle, regulatory guidance states that a non-hormonal barrier method may be necessary for the first seven days of active tablet use to help ensure contraceptive reliability. The full mechanism of ovulation suppression typically requires consistent use.


Q: Is breakthrough bleeding normal when starting Danielle?

Yes, official product information acknowledges that light bleeding or spotting between expected periods is a common occurrence when first starting the pill. This is often an adjustment phase as your body adapts to the new hormones. If this bleeding or spotting persists beyond three months, regulatory guidance indicates it warrants further consultation with a healthcare provider.


Q: How long do the initial side effects of Danielle usually last?

Initial side effects, such as nausea or breast discomfort, are typically reported to be more frequent during the first few months of use. Your body usually adjusts over time, and these temporary effects often lessen or disappear after this initial period.


Q: What happens if I miss a dose of Danielle?

Regulatory documents outline detailed steps to follow for a missed dose based on the specific week of the cycle. These procedures typically involve taking a pill as soon as possible and may require the temporary use of a backup barrier method for a specific duration. A delay of more than 24 hours from your usual time may reduce contraceptive protection.


Q: Is it necessary to take Danielle at the exact same time every day?

Official administration guidelines advise taking the tablet at approximately the same time each day to maintain a consistent hormonal level. While minor variations are possible, reliability may be reduced if intake is delayed by more than 24 hours, which is defined as a missed dose. Consistency is key to efficacy.


Q: Can I switch to Danielle from another type of pill without issues?

Official instructions for switching from another Combined Oral Contraceptive (COC) specify that intake should start preferably the day after the last active tablet of your previous pill, or at the very latest, following the usual hormone-free interval. This procedure helps maintain continuous protection, but it is important to follow the specific instructions provided by a healthcare professional when changing contraceptive brands.


Q: Does Danielle offer benefits beyond its primary intended use?

Yes, official regulatory labeling indicates that in addition to preventing pregnancy, the medication is also specifically indicated for the treatment of moderate acne vulgaris in women who choose to use an oral contraceptive. It may also be used to treat symptoms of heavy menstrual bleeding.


Q: Can Danielle be used to manage heavy periods?

Regulatory documents confirm that the medication is specifically indicated for the treatment of heavy menstrual bleeding in women who have chosen to use an oral contraceptive. The combined hormones can help reduce the volume of menstrual blood loss.


Q: What is the risk of weight gain while taking Danielle?

Clinical trial data lists increased weight as a reported adverse reaction, though it is often listed as a common or less common side effect. It is important to know that changes in body weight or fluid retention have been reported by some users of hormonal contraceptives.


Q: Are there any common but minor side effects of Danielle I should know about?

Official product information notes several common side effects. These can include headache, nausea, breast discomfort or pain, and irregular menstrual periods (such as spotting) that may occur while your body is adjusting to the medication.


Q: Does Danielle affect mood or cause anxiety?

Regulatory documents list mood disorders, including depression and altered mood, as reported adverse reactions in clinical trials. If significant or lasting changes in your emotional state occur while using the pill, official information recommends consulting a healthcare professional.


Q: Does alcohol consumption affect how Danielle works?

Official safety information typically classifies the interaction with alcohol (ethanol) as minor, meaning it is unlikely to directly interfere with the pill's efficacy. However, it is important to discuss all lifestyle factors and substance use with a prescribing professional.


Q: Is Danielle safe to use for women over 35?

Official labeling explicitly contraindicates the use of this pill only in women over the age of 35 who smoke, due to a significantly increased risk of serious cardiovascular events. However, use of any hormonal contraceptive in women over 35, even non-smokers, still requires a full health assessment to evaluate individual risks.


Q: Is Danielle ever prescribed to women who are not on birth control?

Official indications for non-contraceptive uses, such as for acne or heavy bleeding, are limited to females who have elected to use an oral contraceptive for pregnancy prevention. Therefore, it is generally not prescribed to patients who are actively avoiding contraception.


Q: Can I use Danielle if I have a history of migraines?

Regulatory documents state that this medication is contraindicated (should not be used) in women who have a history of migraines with focal neurological symptoms (migraine with aura). A history of migraines without focal neurological symptoms requires a full review of individual risk factors by a healthcare professional before use.


Q: What should I do if I experience nausea when first starting Danielle?

Nausea is a very common side effect, particularly in the first few cycles. If the nausea is continuous and does not subside after the initial adjustment period, official patient counseling recommends seeking advice from a healthcare provider.


Q: Does Danielle protect against sexually transmitted infections?

No, official patient counseling clearly states that hormonal oral contraceptives do not protect against the transmission of HIV (AIDS) or other sexually transmitted diseases (STDs). An additional barrier method, such as a condom, is necessary for this protection.


Q: Is it true that Danielle might affect my future fertility?

Regulatory information indicates that normal cycles and the return to fertility generally occur after stopping treatment. The effect of the pill is intended to be temporary and reversible, and most individuals experience a return to their baseline reproductive function.


Q: Do antibiotics make Danielle less effective?

Regulatory warnings mention that the effectiveness of the pill may be reduced with the concomitant use of certain enzyme-inducing medicines. Certain antibiotic classes, such as ampicillin and tetracyclines, have been associated with reduced efficacy, and patients may be advised to use a backup barrier method.


Q: Can using a tanning bed or being in the sun interact with Danielle?

Patients who have a history of chloasma (a skin condition causing darkened patches) are advised in regulatory warnings to avoid exposure to the sun or ultraviolet radiation (like tanning beds), as the medication may worsen this condition.


Q: Is there a link between Danielle and changes in eyesight?

Regulatory safety information advises that contact lens wearers who develop visual changes or changes in lens tolerance should be assessed by an ophthalmologist. Though rare, certain visual changes have been reported with hormonal contraceptive use.


Q: Does Danielle affect liver function in healthy individuals?

While the pill is contraindicated in severe hepatic (liver) disease, regulatory information suggests that low-dose estrogen oral contraceptives generally show little clinical effect on liver function tests in healthy individuals. Any need for periodic laboratory monitoring is determined by a healthcare provider based on individual patient health factors.


Q: Is it normal to have a shorter or lighter period while on Danielle?

Yes, regulatory data on the pill indicates that its use is generally associated with both decreased blood loss and a decreased incidence of dysmenorrhea (painful periods). It is common for the monthly withdrawal bleed to be lighter than a typical menstrual period.


Q: Are there any known issues with taking Danielle and certain vitamins?

Regulatory counseling reminds patients to inform their doctor about all medications used, including vitamins and herbs, to assess for potential interactions. This is a general caution because some supplements can affect the body's metabolism of the pill's hormones.


Q: Can Danielle interact with supplements like St. John's Wort?

Yes, the herbal supplement St. John's Wort is explicitly listed in regulatory warnings. It can reduce the effect of the pill by inducing (speeding up) the liver enzymes that process the hormones, potentially leading to a loss of contraceptive efficacy.


Q: Can I take Danielle if I have a history of depression?

Official warnings state that women with a history of depression should be carefully observed while taking this medication. If depression recurs or worsens to a serious degree, the pill may need to be discontinued as directed by a healthcare professional.


Q: Does Danielle affect cholesterol levels?

Official data indicates that use of the pill may result in an increase in the mean levels of total cholesterol, HDL cholesterol (often called 'good' cholesterol), and triglycerides. Monitoring may be required in individuals with pre-existing lipid disorders.


Q: Does Danielle make you feel tired or fatigued?

Yes, fatigue is listed as one of the reported adverse reactions that occurred in clinical trials. If fatigue is severe or persistent, regulatory safety principles advise consultation with a healthcare provider.


Q: Are there any dietary restrictions I need to follow while on Danielle?

Regulatory guidance suggests that the consumption of grapefruit or grapefruit juice should be assessed and possibly limited. This is because grapefruit can affect how the body processes one of the active substances, potentially increasing its plasma concentration.

How should Danielle be stored and disposed of?

Storage Conditions and Packaging

The medicine must be stored at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F), with permitted short-term excursions. The tablets must be kept in their original blister pack and a tightly closed container to ensure product stability.

It is required to store the medicine in a cool, dry place, protected from excessive heat, moisture, and direct light, and it must not be frozen. Storage in areas prone to humidity, such as a bathroom, is prohibited.

Child-Safety and Disposal

All medication must be stored in a secure location and kept out of the reach and sight of children.

For disposal of unused or expired tablets, the primary recommended method is through an official drug take-back program. If a take-back option is unavailable, the tablets must be removed from the original packaging, mixed with an undesirable substance (e.g., used coffee grounds or dirt), and placed in a sealed bag before being discarded in the household trash. The product should not be flushed down a toilet or drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Danielle found in:

A-Z Index: